Sponsor intelligence · OTHER
Clinical trials sponsored by
Second Affiliated Hospital, Zhejiang University, School Of Medicine.
Real, source-linked trial activity for Second Affiliated Hospital, Zhejiang University, School Of Medicine: 10 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 20, 2026. Source-linked, daily-refreshed.
NA 5N/A 2PHASE4 1PHASE2 1PHASE3 1
Newest Second Affiliated Hospital, Zhejiang University, School Of Medicine trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 4d ago | SIB Accelerated Hyperfractionated RT for High-Proliferation NSCLC | NA | RECRUITING | ↗ |
| 18d ago | Acupuncture for Generalized Anxiety Disorder | NA | NOT_YET_RECRUITING | ↗ |
| 27d ago | AI-Assisted Novel rbcDNA Detection for Early Gastric Cancer Diagnosis | N/A | NOT_YET_RECRUITING | ↗ |
| 30d ago | Research on Predicting Aortic Remodeling Following TEVAR for Type B Ao | N/A | COMPLETED | ↗ |
| 32d ago | Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for So | NA | RECRUITING | ↗ |
| 41d ago | Blended Cardiac Rehabilitation Training for Cardiology Residents | NA | ACTIVE_NOT_RECRUITING | ↗ |
| 44d ago | Ezetimibe for Arrhythmia Recurrence After AF Ablation | Ph 4 | NOT_YET_RECRUITING | ↗ |
| 44d ago | A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Pr | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 45d ago | Intravascular Lithotripsy Versus Rotational Atherectomy for Severe Cor | NA | NOT_YET_RECRUITING | ↗ |
| 46d ago | Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Second Affiliated Hospital, Zhejiang University, School Of Medicine (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.